The present and future of seizure detection, prediction, and forecasting with machine learning, including the future impact on clinical trials

被引:3
|
作者
Kerr, Wesley T. [1 ]
Mcfarlane, Katherine N. [1 ]
Pucci, Gabriela Figueiredo [1 ]
机构
[1] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA
来源
FRONTIERS IN NEUROLOGY | 2024年 / 15卷
关键词
epilepsy; wearables; internet of things; human-in-the loop; deficiency time; RESPONSIVE NEUROSTIMULATION; INTERNATIONAL-LEAGUE; EPILEPTIC SEIZURES; PLACEBO; METAANALYSIS; DEPRESSION; QUALITY; UTILITY; SCORE; RISK;
D O I
10.3389/fneur.2024.1425490
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Seizures have a profound impact on quality of life and mortality, in part because they can be challenging both to detect and forecast. Seizure detection relies upon accurately differentiating transient neurological symptoms caused by abnormal epileptiform activity from similar symptoms with different causes. Seizure forecasting aims to identify when a person has a high or low likelihood of seizure, which is related to seizure prediction. Machine learning and artificial intelligence are data-driven techniques integrated with neurodiagnostic monitoring technologies that attempt to accomplish both of those tasks. In this narrative review, we describe both the existing software and hardware approaches for seizure detection and forecasting, as well as the concepts for how to evaluate the performance of new technologies for future application in clinical practice. These technologies include long-term monitoring both with and without electroencephalography (EEG) that report very high sensitivity as well as reduced false positive detections. In addition, we describe the implications of seizure detection and forecasting upon the evaluation of novel treatments for seizures within clinical trials. Based on these existing data, long-term seizure detection and forecasting with machine learning and artificial intelligence could fundamentally change the clinical care of people with seizures, but there are multiple validation steps necessary to rigorously demonstrate their benefits and costs, relative to the current standard.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Clinical trials: present and future
    Mitsumoto, H
    AMYOTROPHIC LATERAL SCLEROSIS, 2001, 2 : S10 - S14
  • [2] PRESENT AND FUTURE OF CLINICAL-TRIALS
    VORACKOVA, FV
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1990, 42 : 36 - 38
  • [3] Clinical trials: Past, present, and future
    Gray, William A.
    SEMINARS IN VASCULAR SURGERY, 2008, 21 (02) : 80 - 87
  • [4] The future of automated seizure detection and prediction: Foreword
    Osorio, Ivan
    EPILEPSY & BEHAVIOR, 2011, 22 : S1 - S1
  • [5] Rings in Clinical Trials and Drugs: Present and Future
    Shearer, Jonathan
    Castro, Jose L.
    Lawson, Alastair D. G.
    MacCoss, Malcolm
    Taylor, Richard D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, : 8699 - 8712
  • [6] Herceptin clinical trials: past, present and future
    CL Vogel
    Breast Cancer Research, 3 (Suppl 1)
  • [7] Clinical trials in nuclear medicine: Present and future
    Chaumet-Riffaud, P.
    Cachin, F.
    Couturier, O.
    Desruet, M. -D.
    Kraeber-Bodere, F.
    Talbot, J. -N.
    Vuillez, J. -P.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2009, 33 (05): : 296 - 304
  • [8] Internet for clinical trials: Past, present, and future
    Santoro, E
    Nicolis, E
    Franzosi, MG
    Tognoni, G
    CONTROLLED CLINICAL TRIALS, 1999, 20 (02): : 194 - 201
  • [9] The Past, Present, and Future of Machine Learning APIs
    Martin, Francisco
    ARTIFICIAL INTELLIGENCE RESEARCH AND DEVELOPMENT, 2015, 277 : 4 - 4
  • [10] Machine Learning and NDE: Past, Present, and Future
    Harley, Joel B.
    Sparkman, Daniel
    45TH ANNUAL REVIEW OF PROGRESS IN QUANTITATIVE NONDESTRUCTIVE EVALUATION, VOL 38, 2019, 2102